Ozempic Cash Price 2026: Self-Pay Options Compared
Key Takeaways
- Ozempic's list price is approximately $935–$1,000/month for all dose strengths
- NovoCare self-pay pricing brings injection pens to ~$350/month
- Ozempic tablets (launched May 2026) start at approximately $149/month for lower doses
- Ozempic is FDA-approved for type 2 diabetes — not for weight loss. Wegovy is the weight-loss version
- Using Ozempic off-label for weight loss means insurance is less likely to cover it for that purpose
Ozempic (semaglutide) is FDA-approved for type 2 diabetes — not weight loss. That's an important distinction because it affects insurance coverage, savings card eligibility, and which pricing programs you can access. Wegovy is the semaglutide product specifically approved for weight management.
That said, Ozempic is widely prescribed off-label for weight loss, and many people searching for GLP-1 pricing start with Ozempic. Here's what it actually costs in 2026.
Ozempic Injection Pricing by Dose
| Dose | List Price | NovoCare Self-Pay | TrumpRx (Est.) | GoodRx Coupon |
|---|---|---|---|---|
| 0.25 mg (starter) | ~$935 | ~$350 | ~$350 | Varies |
| 0.5 mg | ~$935 | ~$350 | ~$350 | Varies |
| 1 mg | ~$935 | ~$350 | ~$350 | Varies |
| 2 mg | ~$935 | ~$350 | ~$350 | Varies |
Novo Nordisk reduced Ozempic/Wegovy list prices by roughly 50% in late 2025. NovoCare pricing effective through 2026. Verified July 2026.
Ozempic Tablets: May 2026 Launch
Novo Nordisk rebranded Rybelsus and launched "Ozempic tablets" in May 2026, making oral semaglutide available under the Ozempic brand name. The pricing structure mirrors the Wegovy pill:
- Lower doses: ~$149/month through NovoCare
- Higher doses: ~$299/month through NovoCare
- List price: ~$1,000+ without discounts
Ozempic and Wegovy contain the same molecule (semaglutide) made by the same manufacturer (Novo Nordisk). The difference is the FDA-approved indication: Ozempic is for type 2 diabetes, Wegovy is for chronic weight management. Wegovy has higher maximum doses (2.4 mg and 7.2 mg HD for injection; up to 25 mg for the pill) specifically designed for weight loss. If your primary goal is weight loss and you don't have type 2 diabetes, Wegovy is the appropriate product.
Insurance Coverage for Ozempic
Ozempic generally has better insurance coverage than Wegovy — because diabetes medications are more widely covered than weight-loss medications. If you have type 2 diabetes and are prescribed Ozempic on-label, your insurance is more likely to cover it with standard copays.
If you're using Ozempic off-label for weight loss (no diabetes diagnosis), most insurance plans will not cover it. In that case, you're looking at self-pay pricing or should discuss switching to Wegovy with your provider.
Why Wegovy Is Usually the Better Choice for Weight Loss
If weight loss is your primary goal:
- Wegovy goes to higher doses (2.4 mg injectable, 25 mg oral) — more weight loss at maintenance
- Wegovy is covered by the Medicare Bridge at $50/month — Ozempic is not (unless prescribed for cardiovascular risk reduction)
- Wegovy savings programs are designed for weight-loss patients — Ozempic savings cards are structured for diabetes patients
- Pricing is comparable between the two products through manufacturer channels
Brand-name only (Wegovy, Zepbound, Foundayo)
Check Current Pricing →Paid link · We may earn a commission
Injectable semaglutide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Ozempic's cash price has come down to approximately $350/month through manufacturer channels — competitive with Wegovy injection pricing. But for weight loss specifically, Wegovy offers higher doses, Medicare Bridge eligibility, and savings programs designed for the weight-loss indication. Talk to your provider about which product is right for your diagnosis and insurance situation.
Prices verified as of July 15, 2026. Ozempic is FDA-approved for type 2 diabetes. Off-label use for weight loss should be discussed with your healthcare provider.